Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Construction of recombined lentivirus vector aiming at PKC gamma gene RNA interference and application thereof

A recombinant lentivirus and RNA interference technology, applied in the fields of molecular biology and biomedicine, can solve problems such as inability to guide protein synthesis, gene expression silencing, etc., and achieve high knockdown efficiency, good effect, and no toxic side effects.

Inactive Publication Date: 2010-12-01
CENT SOUTH UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

RNAi interference (RNAi) technology is a new technology that blocks the expression of specific genes, so that it cannot guide the synthesis of corresponding proteins, resulting in the silencing of gene expression.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction of recombined lentivirus vector aiming at PKC gamma gene RNA interference and application thereof
  • Construction of recombined lentivirus vector aiming at PKC gamma gene RNA interference and application thereof
  • Construction of recombined lentivirus vector aiming at PKC gamma gene RNA interference and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a recombined lentivirus vector aiming at PKC gamma gene RNA interference, construction thereof and application thereof. A lentivirus vector of ShRNA aiming at PKC gamma gene is constructed by experiments; a synthesized DNA fragment aiming at the ShRNA is mediated through the lentivirus vector, and transfects a 293T cell with pHelper 1.0 vectors and pHelper 2.0 vectors forculturing; and after the recombined lentivirus vector is acquired, a target cell is transfected to realize RNA interference aiming at the PKC gamma gene. The self-inactivated third generation lentivirus (SIN) is adopted, and the recombined lentivirus vector has the advantages of safety and reliability, unseparated cell infection, long-term expression for the target gene integrated to a target cellgene group, small immunity reaction and the like, and is an ideal vector. The lentivirus vector has interference effect on rat primary culture neuron over 85 percent, so that the recombined lentivirus vector can become a powerful tool for treating gene of chronic neuropathic pain.

Description

Construction and application of a recombinant lentiviral vector targeting PKCγ gene RNA interference technical field The invention belongs to the technical fields of molecular biology and biomedicine. It specifically relates to a recombinant lentiviral vector for PKCγ gene RNA interference and a construction method thereof, and the viral vector is used to prepare medicine for treating chronic neuropathic pain. Background technique (1) PKCγ gene is an important molecular target for the treatment of chronic neuropathic pain. Chronic pain is not only a difficult problem in the medical field, but also has become a major burden on the social economy. According to statistics, more than 320 million people in the world suffer from chronic pain. Neuropathic pain (Neuropathic Pain) is a group of symptoms associated with a variety of peripheral nerve disorders, including diabetes, hypothyroidism, uremia, nutritional deficiencies and chemotherapy drugs (vincristine, cisplatin, etc.)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/867A61K48/00A61P29/00
Inventor 邹望远郭曲练宋宗斌张重刘畅赵媛
Owner CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products